Alsaleh,QA Nanda,A Al-Baghli,NM Dvorak,R
Pemphigus in Kuwait
Int J Dermatol 38;351-6 1999 PV, Kuwait, PF
Amagai,M
Autoimmunity against desmosomal cadherins in pemphigus
J Dermatol. Science 20;92-102 1999 PV, PF, Dsg1, Dsg3, cadherins,
Amagai,M Komai,A Hashimoto,T Shirakata,Y, et al
Usefulness of ELISA using recombinant Desmogleins 1 & 3 for the serodiagnosis of pemphigus
Br J Dermatol 140; 351-357 1999 Dsg 1, Dlsg 3, ELISA, PV, PF, diagnosis, activity
disease,
Amagai,M Tsunoda,K Zillikens,D Nagai,T, et al
The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile
J Am. Acad of Dermatol. 40;167-170 1999 Feb PV, PF, Dsg1, Dsg3, clinical
phenotype
Amagi,M
Autoimunity against desmosomal cadherins in pemphigus
J Dermatol Sci 20;92-102 1999 PV, PF, Dsg1, Dsg3,
Anhalt,GJ
Making sense of antigen & antibodies in pemphigus
J Am Acad Dermatol 40;764-66 1999 May pemphigus, Dsg1, Dsg3,PV, PF, ParaPenvoplakin, periplakin,plakoglobulin
Aoyama,Y Owada,MK Kitajima,Y
A pathogenic autoantibody,PV-IgG, induces phosphorylation of desmoglein 3, & it dissociation for plakoglobin in cultured keratinocytes
Eur J Immunnol 29;2233-2240 1999 PV IgG, Dsg3,
phosphorylation,
Aoyama,Y Kitajima,Y PV-IgG
Causes a rapid depletion of Desmoglein 3 from Triton X-100 soluble pools
J Invest Dermatol 112;67-71 1999 PV, dsg3
Bjarnason,B Flosadottir,E
Childhood, neonatal, & stillborn PV
Int J dermatol 38;680-8 1999 PV, childhood, neonatal,
Bornscheuer,E Zillikens,D Schroder,J-M Sticherling,M
Lack of expression of Interleukin 8 and RANTES in autoimmune bullous skin disease
Dermatol 198;118-21 1999 IL-8, RANTES, neutrophiles, eosinophils,
Bredlich,R-O Grundmann-Kollman,M Behrens,S Kerscher,M, et al
Mychophenolate mofetil monotherapy for PV
Br J Dermatol 141;934 1999 mychophenolate mofetil, cellcept, PV
Brenner,S
Pemphigus & diet. Have we solved the mystery of fogo selvagem?
Adv Exp Med Biol 455;267-9 1999 diet, pemphigus,
Bruckner-Tuderman,L
Hereditary skin diseases of anchoring fibrils
J Dermatol Sci 20;122-33 1999 collagen VII, DEB, COL7A1,
Bystryn,J-C
Is Mycophenolic Acid effective for the Rx of Pemphigus?
Arch Dermatol 135;854 1999 July Mycophenolate, cellcept, PV
Calebotta,A Saenz,AM Gonzales,F Carvalho,M & Castillo,R
PV; benefits of tetracycline as adjuvant rx in a series of 13 patients
Internat. J of Dermatol 38(3);217-221 1999 Mar PV, tetracycline
Chen,SH Chopra,K Evans,TY Raimer,SS, et al
HG in a mother & child
JD Am Acad Dermatol. 40;847-9 1999 HG, child,
TOP
Chorzelski,T Hashimoto,T Maciejewska,B Amagai,M, et al
Paraneoplastic Pemphigus associated with castleman tumor, masthenis gravis & bronchiolitis obliterans
J Am Acad Dermatol 41;393-400 1999 Sept ParaP, castleman tumor,
MG, Dsg 3,
de Bruin, A Muller, E Wyder, M Anhalt, GJ, et al
Periplakin & envoplakin are target antigen in canine & human paraneoplastic pemphigus
J Am Acad Dermatol 40;682-5 1999 May ParaP, periplakin, envoplakin, dog
Ding, X Diaz, LA Fairley, JA Giudice, GJ, et al
The anti-desmoglein 1 autoantibodies in PV sera are pathogenic
J Invest Dermatol 112;739-43 1999 anti-Dsg 1, PV, PF, pathophysiology, autoantibodies
Donnenfeld,ED Perry,HD Wallerstein,A Caronia, RM, et al
Subconjuctival Mitomycin C for the treatment of Ocular Cicatrical Pemphigoid Ophth.
106;72-79 1999 OCP, eyes, mitomycin C,
Egan,Ca Taylor,TB Meyer,LJ Petersen,MJ, et al
The IgA antibody response in clinical subsets of mucous membrane pemphigoid
Dermatol 198;330-335 1999 IgA, CP, MMP,
Egan,CA Meadows,KP
Ulcerative Colitis& Immunobullous disease cured by colectomy
Arch Dermatol 135;214-215 1999 PV, linear IgA, Ulcerative colitis
Enk,AH Knop,J
Mycophenolate is effective in the treatment of PV
Arch Dermatol. 135; 54-56 1999 mychophenolate, cellcept, PV
Ettlin,D
Diagnostic patterns in PV
National Pemphigus Foundation web site 1999 PV, oral involvement
Fan,J-L Memar,O McCormick,DJ Prabhakar,BS
BALB/c mice produce blister-causing antibodies upon immunization with a recombinant human desmoglein 3
J of Immunology 163;6228-6235 1999 Dsg 3, PV,
Feliciani,C Toto,P Amerio,P
In vitro C3 mRNA expression in PV
J of Cutan Med & Surg 3(3);140-144 1999 Jan PV
Fleischli,ME Valek,RH Pandya,AG
Pulse Intravenous Cyclophosphamide in Pemphigus
Arch Dermatol 135;57-61 1999 PV, PF, pulse cyclophosphamide
Foster,CS Ahmed,AR
IV immunoglobulin therapy for OCP
Ophth. 106;2136-43 1999 IVIg, OCP, eyes,
Foster,CS, (reviewed by) Scerra,C
Chronic cicatricial conjunctivitis due to many causes (cicatricial pemphigoid)
Opthalmol. Times pp 38-40 1999 July 15 eyes, CP, OCP,
Garcia-Rio,F Alvarez-Sala,R Pino,JM
The mechanism of respiratory failure in ParaP +reply
NEJM 341;848 1999 ParaP, respiratory failure,
Gaspari,AA
Advances in laboratory evaluation in PV
Archives Derm 135;1418 1999 Nov PV, Dsg3, ELISA,
TOP
Gomi,H Aklyama,M Yakabi,K Nakamura,T, et al
Oesophageal involvement in PV
The Lancet 354;1794 1999 Nov,
Grundmann-Kollmann,M Kaskel,P Leiter,U Kruhn,G, et al
Treatment of PV & bullous pemphigoid with mycophenolate mofetil monotherapy
Arch Dermatol 135;724-725 1999 June PV, BP, mycophenolate, cellcept
Grundmann-Kollmann,M Korting,HC Behrens,S Kaskel,P, et al
Mycophenolate Mofetil; a new theraputic option in treatment of blistering autoimmune diseases
J Am Acad Dermatol 40;957-60 1999 June mycophenolate, cellcept, PV, BP
Harman,KE Jancin,B (reporter)
New seromarker found for severe PV
Skin & Allergy News 30(7);36 1999 PV, Dsg1, Dsg3,
Harman,KE Gratian,MJ Bhogal,BS Çhallecombe,SJ, &Black,M
The clinical significane of autoantibodies to desmoglein 1 in 78 cases of PV
SID Meeting 1999 abstract # 273 1999 PV, Dsg 1, antibodies
Hashimoto,T
Skin diseases related to abnormality in desmosomes & hemidesmosomes- editorial review
J Dermatol. Sci 20;81-84 1999 desmosomes, hemidesmosomes, Dsg 1, Dsg 3, Dsc 1-3, PV, PF, BP, OCP,
Heilborn,JD Stahle-Backdahl,M Albertioni,F Vassilaki,I, et al
Low dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigus
J Am Acad Dermatol 40;741-9 1999 BP, pulse methotrexate
Hertl,M Riechers,R
Analysis of the T cells that are potentially involved in autoantibody production in PV
J of Dermatol 26(11);748-52 1999 Nov T cells, PV, autoantibodies, TH1, TH2,
Hoang-Xuan,T Robin,H Demers,PE Heller,M , et al
Pure Ocular Cicatricial Pemphigoid
Ophthal. 106;355-361 1999 OCP, CP, eyes, POCP
Hodak,E Lapidoth,M David,M
Effect of colcicine in the subcorneal pustular dermatosis type fo IgA pemphigus
J Am Acad of Dermatol. 40; 91-94 1999 Jan colchicine, IgA pemphigus
Ishii,K Amagai,M Komai,A Ebihara,T, et al
Dsg 1 & Dsg 3 are the target autoantigens in Herpetiform Pemphigus (HP)
Arch Dermatol 135;943-47 1999 Dsg 1, Dsg 3, HP, PF, PV,
Jiao,D Bystryn,J-C
Relation between antibodies to BP180 & gender in bullous pemphigoid
J Am Acad Dermatol 41;269-70s 1999 Aug BP, antibodies
Jolles,S Dip,RC Hughes,J Rustin,M
Theraputic failure of high-dose intravenous immunoglobulin in PV
J Am.Acad. of Dermatol. 40;499-500 1999 March PV, IVIG
Joly,P Mokhtar,I Gilbert,D Thomine,E, et al
Immunoblot & immunoelectronmicroscopic analysis of endemic Tunisian pemphigus
Br J Dermatol 140;44-9 1999 PF, Tunisian pemphigus,
Jonkman,MF
Herditary skin diseases of hemidesmosomes
J Dermatol Sci 20;103-21 1999 hemidesmosomes,
Jung,M Kippes,W Messer,G Zillikens,D, & Rzany,B
Increased risk of bullous pemphigoid in males & very old patients
J Am Acad Dermatol 41;266-8 1999 Aug BP
Kitajima,Y Sato,M Aoyama,Y
PV IgG causes internalization of clusters of Desmoglein 3 but not of split desmosomes
SID Meeting 1999 abstact 266 1999 PV, dgl3, PV IgG
TOP
|
Kobayashi,TK Kaneko,C Sugishima,S Kusukawa,J, & Kameyama,T
Scrape cytology of oral pemphigus
Acta Cytologica 43 (2);289-94 1999 Mar-April PV, oral involvement,
Kricheli,D David,M Frusic-Zlotkin,M Goldsmith,D, et al
The distribution of PV-IgG subclasses & their reactivity to Desmoglein 1 & 3 in pemphigus patients & their first degree relatives
SID Meeting 1999 abstact # 550 1999 PV, dsg1, dsg3, relatives
Larkin,G Lightman,S
Mycophenolate Mofetil (Cellcept) A useful Immunosupressive in Inflammatory Eye Disease
Ophthal. 106;370-374 1999 eyes, mycophenolate, cellcept
Lebrun-Vignes,B Roujeau,J Bernard,P Delaporte,E, et al
Prednisone is more effective than Presnisolone Metasulfobenzoate in the treatment of Bullous Pemphigoid
Arch Dermatol 135;89-90 1999 BP, pred
Lenz,P Amagai,M Volc-Platzer,B Stingl,G, et al
Desmoglein 3-Elisa; a PV specific diagnostic tool
Arch Dermatol 135;143-148 1999 PV, dsg3, dsg3-elisa
Leverkus,M Schmidt,E Lazarova,Z Brocker,E-B, et al
Antiepiligrin Cicatricial Pemphigoid
Arch Dermatol. 135;1091-8 1999 CP, AECP, lamina 5,
Lin,M-S Ghria,MA Swartz,SJ Diaz,LA, et al
Identification & characterization of epitopes recognized by T Lymphocytes and autoantibodies from patients with Herpes Gestationis
J Immunol 162;4991-7 1999 Herpes gestationis,
pemphigoid gestationis, PG, BP180, Th1, Th2, MCW-1, NC16A, pregnancy,
TOP
Liu,Z Zhou,X Ding,X Chen,R, et al
The role of neutophil elastase, gelatinous B & plasmin/plasminogen activator in PF & PV in mice
SID Meeting 1999 abstract # 562 1999 PV, PF
Liu,Z Zhou,X Fleming,M Giudice,G & Diaz,LA
Cellular event in experimental Bullous Pemphigoid;Mast cells but not T or B lymphocytes, Natural killer cells or macrophages, play a major role in the early stage of subepidermal blistering
SID Meeting 1999 Abstract # 202 1999 BP
Lombardi,ML Mercuro,O Ruocco,V Schiavo,AL, et al
Common Human leukocyte antigen alleles in PV & PF Italian patients
J Invest Dermatol 113;107-110 1999 July PV, PF, HLA,
Mahoney,MG Wang,Z Rothenberger,K Koch,PJ, Amagai,M, & Stanley,JR
Explanations for the clinical & microscopic localization of lesions in PF & PV
J Clin Invest 103(4);461-8 1999 Feb PF, PV, antibodies, dsg1, dsg3
Mahoney,MG Wang,ZH Stanley,JR
PV & PF antibodies are pathogenic in plasminogen activator knockout mice + editorial
J of Invest Dermatol 113;22-5 1999 July PV, PF, antibodies, plasminogen activator,
McGrath,JA
Heritary diseases of desmosomes
J Dermatol Sci 20;85-91 1999 Dsg1, Dsg3, desmosomes,hereditary diseases, H-H, darier disease,
McKusick,V
Familial PV
www.ncbi.nlm.nih.ov/htbin-post/Omim 1999 PV, familial
Miyagawa,S Amagai,M Iida,t Yamamoto,Y
Late development of antidesmoglein 1 antibodies in PV; correlation with disease progression
Br J Dermatol 141;1084-87 1999 PV, autoantibodies, Dsg 1, Dsg 3, epitope spread,
Miyagawa,S Amagai,M Niizeki,H yamashina,Y, et al
HLA-DRB1 polymorphisms & autoimmune responses to desmoglein in Japanese patients with pemphigus
Tissue Antigen 54;333-40 1999 HLA, HLA-DRB1, PV, PF,
Miyagawa,S Amagai,M Nitzeki,H Yamashina,Y, et al
Polymorphic amino acid residues of HLA-DRB1*04 & DRB1*14 alles are involved in autoimmune responses to desmoglein 3
J Invest Dermatol 112;567 1999,
Nishifugi,K Kuwana,M Iwasaki,T Nishikawa,T, & Amagai, M
Requirements of CD4+ T cell collaboration for the autoantibody response to desmoglein 3 in PV
SID annual meeting 1999` abstract # 056 1999 CD4+, Tcells,
dsg3, antibodies
Nishikawa,T Desmoglein ELISAs
A Novel Diagnostic Tool for Pemphigus
Arch Dermatol 135;195-196 1999 Feb Elisa, Dsg1, dsg3,PV, PF
Nousari,HC Anhalt, GJ
Pemphigus & bullous pemphigoid
Lancet 354;667-671 1999 Aug 21 review, PV, PF, BP, treatment,
Nousari,HC Kimyai-Asadi,A Ketabchi,N Diaz,LA, et al
Severe nonepidemic PF presenting in the postpartum period
J Am Acad Dermatol. 40;845-46 1999 PF, pregnacy,
Nousari,HC Sragovich,A Kimyai-Asadi,A Orlinsky,D & Anhalt,GJ
Mycophenolate mofetil in autoimmune & inflammatory skin disorders
J Am Acad of Dermatol. 40;265-268 1999 Feb mychophenolate, cellcept, PV, BP,
Nousari,HC Anhalt, GJ
The role of Mycophenolate Mofetil in the management of Pemphigus
Arch Dermatol 135;853-854 1999 July mycophenolate, cellcept, PV, PF
TOP
Nousari,HC Brodsky,RA Jones,RJ Grever,MR & Anhalt,GJ
Immunoablative high-dose cyclophosphamide without stemcell rescue in PNP; report of case & review of this new rx for severe autoimmune disease
J Am Acad Dermatol 40;750-4 1999 cyclophosphamide, ParaP, autoimmune disease,
Nousari,HC Deterding,R Wojtczack,H Aho, S, et al
The Mechanism of Respiratory Failure in Paraneoplastic Pemphigus
NEJM 340;1406-1410, (+ letter ed 341;848) 1999 May (1999 Sept) ParaP, respiratory failure,
Nousari,HC Rencic,A Hsu,R Yancey,KB, Anhalt,GJ Anti-Epiligrin
Cicatricial Pemphigoid with antibodies against the 2 subunit of Laminin 5
Arch Dermatol 135;173-176 1999 CP, anti-epigrin CP,
Ogata,K Yasuda,K Matsushita,M Kodama,H
Sucessful treatment of adolescent PV by immunoadsorption method
J Dermatol 26;236-9 1999 PV, immunoadsorption, treatments, child,
Pacheco-Garcia, U Tovar-Rivera,T Padierna-Olivos,L Rojas-Espinosa,O, et al
Altered pattern of connectivity in serum immunoglobulins from PV patients
Scand. J of Immunol. 49(4);424-30 1999 Apr IVIG, PV, etiology
Pleyer,U Nielsen,U Mondino,B
Clinical & immunological characteristics of oculomucocutaneous disorders
Immuno-Ophthalmology(text), Pleyer,u,Zierhut M, Behrens-Baumann W (eds) vol 30; 62-83 1999 eyes, review, PV, OCP, EM, SJS, TEN,
Proby,C Fujii,Y Owaribe,K Nishikawa,T et al
Human autoantibodies against HD1/plectin in paraneoplastic pemphigus
J of Invest. Dermatol. 112(2);153-6 1999 Feb ParaP, plectin, antibodies
Rico,MJ Benning,C Weingart,ES Streilein,RD, et al
Characterization of skin cytokines in BP & PV
Br J Dermatol 140;1079-86 1999 PV, BP, Th1, Th2, IL-2, IL-4, IL -5, IL-10, IL-12, IL-13, IFN,
Riechers,R Grotzinger,J Hertl,M
HLA Class II restriction of autoreactive T cell responses in PV; review of the literature & potential applications for the development of a specific immunotherapy
Autoimmunity 30;183-196 1999 HLA Class II , autoreactive T cell ,PV, review, immunotherapy,Th1, Th2, IgG4, IgE, IL-4, IL13, IL5,
Robinson,ND Hashimoto,T Amagai,M Chan,L
The new pemphigus variants
J Am Acad Dermatol 40;649-71 1999 PH, IgAP, ParaP,
Scruvener,Y Heid,E Grossbans,E Cribier,B
Erythrodermic BP (EBP)
JAm Acad Dermatol 41;658-59 1999 Oct BP, EBP,
Scully,C Paes De Aleida,O Porter,SR Gilkes,JJH
PV; the manifestations & long-term management of 55 pts with oral leisons
Brit J of Dermatol. 140;84-89 1999 PV, oral involvement
Setterfield,J Shirlaw,PJ Bhogal,BS Tilling,K, et al
CP; serial titres of circulating IgG & IgA antibasmentment membrane antibodies corrolate with disease activity
Br J Dermatol 140;645-50 1999 CP, Autoantibodies, activity, IgG, IgA
Smith,TJ Bystryn,J-C
Methotrexate as an adjuvant for PV
Arch Dermatol. 135;1275-6 1999 Oct PV, Methotrexate,
TOP
Stanley,JR
Therapy of PV
Arch Dermatol 135;76-78 1999 PV, therapy
Torzecka,JD Sysa-Jedrzejowska,A Waszczykowska,E Wozniacka,A, et al
Immunopathological examination of esophagus as a useful criterion of cure in PV J
European Acad of dermatol & Venereology 12;115-8 1999 PV, remission, esophagus,
Toto,P Feliciani,C Amerio,P Suzuki,H, et al
IL-10 immunomodulation in treatment of pemphigus
SID Meeting 1999 abstract # 552 1999 PV, IL-10, treatment
Triffet,MK Gibson,LE Leiferman,KM
Severe subepidermal blistering disorder with the features of PB & HG
J Am Acad Dermatol. 40;797-801 1999 BP, HG, PG,
Udey,MC Stanley, JR
Pemphigus-Disease of antidesmosomal autoimmunity
JAMA 282;572-576 1999, Aug 11 PV, PF, ParaP, dsg1, dsg3, review
Wang,BY Krishnan,S Isenberg,HD
Mortality assoc with concurrent strongyloidosis & CMV infection in a patient on steroid therapy
Mount Sinai J Med 66;128-132 1999 Mar PV, CMV, death
Wang,Z Mahoney,MG kStanley,JR
Plasma activator is not requires for blister formation in pemphigus
Annual Meeting SID abstract # 055 1999 pemphigus, etiology, plasminogen activator
Xue,W Hashimoto,K
PV IgG regulates expression of urokinase receptor & junctional proteins that may contribute to acantholysis
J Am Acad Dermatol 41(3);462-3 1999 PV, uPAR, urokinase receptor, acantholysis,
Zillikens,D
Acquired skin diseases of hemidesmosomes
J Dermatol Sci 20;134-54 1999 BP, BP180, BP230,
TOP
|
